Headquarters
201 MCCLANAHAN ST SW, ROANOKE, VA 24014-1709, US
ROANOKE, VA, US
COEURATIVE INC
From the company
Coeurative, Inc. is developing a pharmaceutical management strategy for Coronary Artery Disease and its main symptom complex, Angina Pectoris. The company is harnessing a cellular response to a deficiency in blood and oxygen to open a coronary artery more effectively and selectively than currently available vasodilators, with a focus on patients with INOCA and refractory angina pectoris. Its lead compound CR-0305 uses a proprietary dual-mechanism approach, with IND-enabling studies underway and Phase 1 trials planned for 2028.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.